• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Hanami Kentaro  花見 健太郎

ORCIDConnect your ORCID iD *help
… Alternative Names

HANAMI Kentaro  花見 健太郎

花見 健太郎  ハナミ ケンタロウ

Less
Researcher Number 50441853
Other IDs
Affiliation (Current) 2025: 産業医科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help 2020 – 2021: 産業医科大学, 医学部, 講師
2014 – 2019: 産業医科大学, 医学部, 助教
2009: 産業医大, 医学部, 研究員
2008: University of Occupational and Environmental Health, Japan, 医学部, 専門修練医
Review Section/Research Field
Principal Investigator
Collagenous pathology/Allergology / Basic Section 54020:Connective tissue disease and allergy-related / 膠原病・アレルギー・感染症内科学
Keywords
Principal Investigator
ドパミン受容体シグナル / 破骨細胞 / 樹状細胞 / シグナル伝達 / 抗原提示能 / 骨リモデリング / 神経伝達物質 / Jak3 / stat6
  • Research Projects

    (4 results)
  • Research Products

    (23 results)
  • Co-Researchers

    (5 People)
  •  Elucidation of pathophysiology and development of new treatments with the neurotransmitter dopamine for rheumatoid arthritisPrincipal Investigator

    • Principal Investigator
      HANAMI KENTARO
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 54020:Connective tissue disease and allergy-related
    • Research Institution
      University of Occupational and Environmental Health, Japan
  •  The mechanism of dendritic cell-derived osteoclasts in the pathogenesis of arthritis.Principal Investigator

    • Principal Investigator
      Hanami Kentaro
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Collagenous pathology/Allergology
    • Research Institution
      University of Occupational and Environmental Health, Japan
  •  Dopamine receptor signaling regulates human osteoclastogenesis.Principal Investigator

    • Principal Investigator
      HANAMI Kentaro
    • Project Period (FY)
      2014 – 2015
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Collagenous pathology/Allergology
    • Research Institution
      University of Occupational and Environmental Health, Japan
  •  樹状細胞Stat6制御による新規関節リウマチの治療の開発Principal Investigator

    • Principal Investigator
      花見 健太郎
    • Project Period (FY)
      2008 – 2009
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      膠原病・アレルギー・感染症内科学
    • Research Institution
      University of Occupational and Environmental Health, Japan

All 2022 2021 2020 2019 2018 2017 2016 2015 2014

All Journal Article Presentation

  • [Journal Article] Eosinophilic granulomatosis with polyangiitis exhibits T cell activation and IgG4 immune response in the tissue; comparison with IgG4-related disease2022

    • Author(s)
      Kubo Satoshi、Kanda Ryuichiro、Nawata Aya、Miyazaki Yusuke、Kawabe Akio、Hanami Kentaro、Nakatsuka Keisuke、Saito Kazuyoshi、Nakayamada Shingo、Tanaka Yoshiya
    • Journal Title

      RMD Open

      Volume: 8 Issue: 1 Pages: e002086-e002086

    • DOI

      10.1136/rmdopen-2021-002086

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19K08926
  • [Journal Article] Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD2022

    • Author(s)
      Todoroki Yasuyuki、Kubo Satoshi、Nakano Kazuhisa、Miyazaki Yusuke、Ueno Masanobu、Satoh-Kanda Yurie、Kanda Ryuichiro、Miyagawa Ippei、Hanami Kentaro、Nakatsuka Keisuke、Saito Kazuyoshi、Nakayamada Shingo、Tanaka Yoshiya
    • Journal Title

      Rheumatology

      Volume: Mar 14:keac165 Issue: 12 Pages: 4875-4884

    • DOI

      10.1093/rheumatology/keac165

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19K08926
  • [Journal Article] Efficacy and safety of high-dose of mycophenolate mofetil compared with cyclophosphamide pulse therapy as induction therapy in Japanese patients with proliferative lupus nephritis2021

    • Author(s)
      Ohkubo Naoaki、Iwata Shigeru、Nakano Kazuhisa、Miyagawa Ippei、Hanami Kentaro、Fukuyo Shunsuke、Miyazaki Yusuke、Kawabe Akio、Nakayamada Shingo、Tanaka Yoshiya
    • Journal Title

      Modern Rheumatology

      Volume: - Issue: 6 Pages: 1077-1085

    • DOI

      10.1093/mr/roab113

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K08900, KAKENHI-PROJECT-19K08926
  • [Journal Article] Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus2021

    • Author(s)
      Miyazaki Yusuke、Nakayamada Shingo、Sonomoto Koshiro、Kawabe Akio、Inoue Yoshino、Okubo Naoaki、Iwata Shigeru、Hanami Kentaro、Tanaka Yoshiya
    • Journal Title

      Rheumatology

      Volume: Dec 28:keab953. Issue: 9 Pages: 3614-3626

    • DOI

      10.1093/rheumatology/keab953

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19K08926
  • [Journal Article] The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.2020

    • Author(s)
      Miyagawa I, Nakano K, Nakayamada S, Iwata S, Hanami K, Fukuyo S, Kubo S, Kawabe A, Miyazaki Y, Inoue Y, Ueno M, Ohkubo N, Fujita Y, Tanaka Y.
    • Journal Title

      Int J Rheum Dis.

      Volume: 23(4) Issue: 4 Pages: 549-558

    • DOI

      10.1111/1756-185x.13792

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19K08926
  • [Journal Article] 5-year remission rate after the discontinuation of adalimumab in patients with rheumatoid arthritis: Long-term follow-up results of the HONOR study.2020

    • Author(s)
      Yamaguchi A, Hirata S, Kubo S, Fukuyo S, Hanami K, Nakano K, Nakayamada S, Saito K, Tanaka Y.
    • Journal Title

      Mod Rheumatol.

      Volume: 15 Issue: 5 Pages: 1-8

    • DOI

      10.1080/14397595.2019.1702141

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19K08926
  • [Journal Article] A case of eosinophilic granulomatosis with polyangiitis as a mimicker of IgG4-related disease2020

    • Author(s)
      Kanda Ryuichiro、Kubo Satoshi、Nakano Kazuhisa、Kawabe Akio、Nawata Aya、Hanami Kentaro、Nakayamada Shingo、Tanaka Yoshiya
    • Journal Title

      Modern Rheumatology Case Reports

      Volume: 4 Issue: 2 Pages: 278-282

    • DOI

      10.1080/24725625.2020.1759200

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19K08926
  • [Journal Article] Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders.2020

    • Author(s)
      Nakano K, Saito K, Nawata A, Hanami K, Kubo S, Miyagawa I, Fujino Y, Nakayamada S, Tanaka Y.
    • Journal Title

      Mod Rheumatol.

      Volume: 27 Issue: 1 Pages: 1-7

    • DOI

      10.1080/14397595.2020.1741870

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19K08926
  • [Journal Article] Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus.2019

    • Author(s)
      Miyagawa I, Nakano K, Nakayamada S, Iwata S, Hanami K, Fukuyo S, Kubo S, Inoue Y, Ueno M, Tanaka Y.
    • Journal Title

      Int J Rheum Dis.

      Volume: 22(3) Issue: 3 Pages: 434-442

    • DOI

      10.1111/1756-185x.13387

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16K09915
  • [Journal Article] Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis.2018

    • Author(s)
      Ishikawa Y, Iwata S, Hanami K, Nawata A, Zhang M, Yamagata K, Hirata S, Sakata K, Todoroki Y, Nakano K, Nakayamada S, Satoh M, Tanaka Y.
    • Journal Title

      Arthritis Res Ther

      Volume: 20 Issue: 1 Pages: 240-240

    • DOI

      10.1186/s13075-018-1737-2

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16K09914, KAKENHI-PROJECT-16K09915
  • [Journal Article] Pleurisy Caused by <i>Mycobacterium abscessus</i> in a Young Patient with Dermatomyositis: A Case Report and Brief Review of the Literature2018

    • Author(s)
      Noguchi S, Hanami K, Miyata H, Torii R, Shimabukuro I, Kubo S, Obata H, Yoshii C, Yatera K.
    • Journal Title

      Intern. Med.

      Volume: 57 Issue: 7 Pages: 997-1002

    • DOI

      10.2169/internalmedicine.9537-17

    • NAID

      130006602626

    • ISSN
      0918-2918, 1349-7235
    • Language
      English
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-16K09915
  • [Journal Article] Comparison of efficacy of TNF inhibitors and abatacept in patients with rheumatoid arthritis; Adjusted with propensity score matching.2018

    • Author(s)
      Kubo S, Nakayamada S, Nakano K, Sawamukai N, Hirata S, Hanami K, Saito K1, Tanaka Y.
    • Journal Title

      Clin Immunol.

      Volume: 191 Pages: 67-74

    • DOI

      10.1016/j.clim.2018.03.018

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16K09915
  • [Journal Article] Peripheral Immunophenotyping Identifies Three Subgroups Based on T Cell Heterogeneity in Lupus Patients.2017

    • Author(s)
      Kubo S, Nakayamada S, Yoshikawa M, Miyazaki Y, Sakata K, Nakano K, Hanami K, Iwata S, Miyagawa I, Saito K, Tanaka Y.
    • Journal Title

      Arthritis Rheumatol.

      Volume: 69(10) Issue: 10 Pages: 2029-2037

    • DOI

      10.1002/art.40180

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K09915, KAKENHI-PROJECT-17K10010, KAKENHI-PROJECT-17K16218
  • [Journal Article] Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice.2016

    • Author(s)
      Hirata S, Li W, Kubo S, Fukuyo S, Mizuno Y, Hanami K, Sawamukai N, Yamaoka K, Saito K, Defranoux NA, Tanaka Y.
    • Journal Title

      Mod Rheumatol

      Volume: 26 Issue: 6 Pages: 850-856

    • DOI

      10.3109/14397595.2016.1153449

    • Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K08956, KAKENHI-PROJECT-16K09915
  • [Journal Article] Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice.2016

    • Author(s)
      Hirata S, Li W, Kubo S, Fukuyo S, Mizuno Y, Hanami K, Sawamukai N, Yamaoka K, Saito K, Defranoux NA, Tanaka Y.
    • Journal Title

      Mod Rheumatol.

      Volume: Mar 30 Pages: 1-7

    • Data Source
      KAKENHI-PROJECT-26860764
  • [Journal Article] Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab.2015

    • Author(s)
      Hirata S, Marotta A, Gui Y, Hanami K, Tanaka Y.
    • Journal Title

      Arthritis Res Ther.

      Volume: 17 Issue: 1 Pages: 280-280

    • DOI

      10.1186/s13075-015-0799-7

    • Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-25460713, KAKENHI-PROJECT-26860764
  • [Journal Article] Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matching.2015

    • Author(s)
      Kubo S, Nakayamada S, Nakano K, Hirata S, Fukuyo S, Miyagawa I, Hanami K, Saito K, Tanaka Y.
    • Journal Title

      Ann Rheum Dis.

      Volume: Aug 5 Issue: 7 Pages: 207784-207784

    • DOI

      10.1136/annrheumdis-2015-207784

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26860764, KAKENHI-PROJECT-16K09915
  • [Journal Article] Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study.2014

    • Author(s)
      Tanaka Y, Hirata S, Kubo S, Fukuyo S, Hanami K, Sawamukai N, Nakano K, Nakayamada S, Yamaoka K, Sawamura F, Saito K.
    • Journal Title

      Ann Rheum Dis

      Volume: in press Issue: 2 Pages: 389-95

    • DOI

      10.1136/annrheumdis-2013-204016

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-25460713, KAKENHI-PROJECT-26860764
  • [Journal Article] Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis.2014

    • Author(s)
      Miyagawa I, Nakayamada S, Saito K, Hanami K, Nawata M, Sawamukai N, Nakano K, Yamaoka K, Tanaka Y.
    • Journal Title

      Mod Rheumatol.

      Volume: 24(3) Issue: 3 Pages: 405-9

    • DOI

      10.3109/14397595.2013.844294

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-26860764
  • [Journal Article] Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors.2014

    • Author(s)
      Tanaka Y, Takeuchi T, Amano K, Saito K, Hanami K, Nawata M, Fukuyo S, Kameda H, Kaneko Y, Kurasawa T, Nagasawa H, Hoshi D, Sato E, Yamanaka H.
    • Journal Title

      Mod Rheumatol.

      Volume: 24(3) Issue: 3 Pages: 399-404

    • DOI

      10.3109/14397595.2013.843757

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-26860764
  • [Presentation] 関節リウマチに対するTocilizumabとAdalimumab投与によるMBDAスコアの12バイオマーカーの挙動比較2015

    • Author(s)
      花見健太郎 , 平田信太郎 , 宮川一平 , 久保智史 , 福與俊介 , 澤向範文 , 中野和久 , 中山田真吾 , 齋藤和義 , 田中良哉
    • Organizer
      日本リウマチ学会 (第59回)
    • Place of Presentation
      名古屋国際会議場(愛知県・名古屋市)
    • Year and Date
      2015-04-23
    • Data Source
      KAKENHI-PROJECT-26860764
  • [Presentation] 血清14-3-3ηと関節リウマチの疾患活動性の関連についての検討2015

    • Author(s)
      花見健太郎 , 平田信太郎 , 宮川一平 , 久保智史 , 福與俊介 , 澤向範文 , 中野和久 , 中山田真吾 , 齋藤和義 , 田中良哉
    • Organizer
      日本リウマチ学会 (第59回)
    • Place of Presentation
      名古屋国際会議場(愛知県・名古屋市)
    • Year and Date
      2015-04-23
    • Data Source
      KAKENHI-PROJECT-26860764
  • [Presentation] Serum 14-3-3η is a Modifiable, Mechanistic Biomarker that Predicts Tocilizumab Response2015

    • Author(s)
      Kentaro Hanami, Shintaro Hirata, Anthony Marotta, Yoshiya Tanaka
    • Organizer
      欧州リウマチ学会 (第16回)
    • Place of Presentation
      ローマ(イタリア)
    • Year and Date
      2015-06-10
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26860764
  • 1.  久保 智史 (70461548)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results
  • 2.  田中 良哉 (30248562)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 9 results
  • 3.  YAMAGATA KAORU
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 4.  HIRATA Shintaro
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 3 results
  • 5.  岩田 慈
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi